Clinical Trial Update: Dendritic Cell Vaccination for Patients with Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/Phase 2 clinical study evaluating a dendritic cell vaccine in patients with solid tumors, including glioblastoma and renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Glioblastoma
• Malignant Mesothelioma
• Renal Cell Carcinoma
• Sarcoma

Drugs mentioned

• Dendritic cell vaccine

Snippet

Sponsor: University Hospital, Antwerp | Conditions: Glioblastoma, Renal Cell Carcinoma | Phase 1, Phase 2 | Status: COMPLETED